Zhen-gang Yuan
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
Journal: Clinical and translational medicine
Published: January 19, 2024
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Journal: Frontiers in immunology
Published: October 09, 2023
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.
Journal: Science translational medicine
Published: July 12, 2023
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
Journal: Journal of clinical and translational hepatology
Published: March 20, 2023
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer.
Journal: Nature communications
Published: September 15, 2022
Current and emerging immunotherapeutic approaches for biliary tract cancers.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: June 23, 2022
Impact of antithrombotic drugs on the accuracy of fecal occult blood testing for advanced colorectal neoplasia screening: a meta-analysis and systematic review.
Journal: Zeitschrift fur Gastroenterologie
Published: May 17, 2022
Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.
Journal: Frontiers in immunology
Published: May 13, 2022
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
Journal: Science translational medicine
Published: May 13, 2019
New Strategies for the Treatment of Solid Tumors with CAR-T Cells.
Journal: International journal of biological sciences
Published: November 12, 2015
Clinical and laboratory features of four cases with IgM multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 15, 2013
The efficacy and safety analysis of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 15, 2013
Last Updated: 09/26/2026